Related LncRNAs
ID	lncRNA Name	Disease	Method	Sample	Expression pattern	Dysfunction type	Description	PMID	Source
EL0578	HOTAIR	diffuse large B-cell lymphoma	The reverse transcription‑polymerase chain reaction & Western blotting	N/A	up-regulated	N/A	HOTAIR was significantly correlated with tumor size, clinical stage, B symptoms and International Prognostic Index scores	27122348
EL0600	HULC	diffuse large B-cell lymphoma	in a cohort of DLBCL	DLBCL tissues and cell lines	up-regulated	N/A	HULC was closely related to DLBCL characteristics	27044827
EL0850	LUNAR1	diffuse large B-cell lymphoma	Quantitative real-time PCR, knockdown	Diffuse large B-cell lymphoma (DLBCL) tissues and cell lines	N/A	interaction	The higher expression of LUNAR1 was significantly correlated with stage, rituximab and IPI. Univariate and multivariate analyses showed that LUNAR1 expression served as an independent predictor for overall survival and progression-free survival. LUNAR1 may serve as a candidate prognostic biomarker through growth regulation in DLBCL.	26796267
EL0878	MIR17HG	diffuse large B-cell lymphoma	qPCR, Northern blot etc.	cell lines (OCI-Ly4, OCI-Ly7, OCI-ly8 etc.)	up-regulated	locus	C13orf25 (MIR17HG) is a target for 13q31-q32 amplification in malignant lymphoma.	15126345	LncRNADisease Lnc2Cancer
EL1063	PEG10	diffuse large B-cell lymphoma	qPCR, knockdown etc.	DLBCL tissue, cell lines (OCI-LY-3, OCI-LY-7, OCI-LY-10 etc.)	up-regulated	expression	We first found that the expression of PEG10 was upregulated in DLBCL tumorous tissues and that cell lines compared with the normal. Moreover, we illustrated that PEG10 was significantly correlated with B symptoms, IPI score, CHOP-like treatment and rituximab.	25864113	Lnc2Cancer